STAT+: What Medicare incentives for AI-based devices mean for tech companies — and hospitals
Reported by STAT News · all stories from statnews.com
Editorial digest
Medicare's financial incentives for artificial intelligence-powered devices hold significant implications for both technology firms and healthcare organizations. These policies shape adoption and innovation.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/13/2026
STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices
An investigation examines Commure and Medicare's AI device incentives.
- Trusted health newsroom11/5/2026
STAT+: What the midterms could mean for the future of health AI
Upcoming midterm election outcomes could reshape regulatory policies and federal oversight for medical artificial intelligence technologies.
- Trusted health newsroom11/12/2026
STAT+: New documents raise more questions about Medicare’s AI prior-authorization experiment
Newly surfaced records prompt growing scrutiny regarding Medicare's pilot initiative using artificial intelligence for coverage approvals.
- Trusted health newsroom9/29/2026
STAT+: The last ‘breakthrough’ devices to get special treatment from Medicare
The article discusses the final 'breakthrough' devices receiving special Medicare treatment.
- Trusted health newsroom11/5/2026
STAT+: Medicare delays controversial remote patient monitoring rule to 2029
Federal regulators have postponed a contentious Medicare remote patient monitoring policy update until 2029.
- Trusted health newsroom11/6/2026
STAT+: After Medicare punts RPM overhaul to 2029, advocates see window to fight back
Advocates plan to challenge Medicare's remote monitoring overhaul after officials postponed the policy update to 2029.
